Vmn1r107 Inhibitors consist of a variety of chemicals that target different aspects of cellular signaling and enzymatic activity, indirectly affecting the function of vomeronasal 1 receptor 107. This receptor is involved in the detection of pheromones, playing a critical role in mammalian behavioral responses. The indirect inhibitors listed are not specific antagonists to Vmn1r107 but rather influence the cellular and molecular context in which the receptor operates. The first key aspect of these inhibitors is their role in modulating critical signaling pathways. Compounds like PD 98059, LY294002, Wortmannin, and SB 203580 target crucial kinases and enzymes such as MEK, PI3K, and p38 MAP kinase. These molecules are central to various cellular processes, including signal transduction, cell growth, and differentiation. Inhibiting these pathways can indirectly affect the signaling milieu of Vmn1r107, potentially altering the receptor's response to external stimuli or its expression levels.
Another important aspect is the inhibition of specific enzymes and kinases that could impact Vmn1r107 indirectly. For instance, Go 6983, Chelerythrine Chloride, Bisindolylmaleimide I, and Staurosporine are known to inhibit Protein Kinase C (PKC) and other kinases. These enzymes play roles in numerous cellular processes, and their inhibition can lead to altered cell signaling dynamics that may influence Vmn1r107 activity. Similarly, Y-27632 and PP2 target ROCK and Src family kinases, respectively, which are involved in various aspects of cellular regulation, including cytoskeletal organization and cell migration. In summary, Vmn1r107 Inhibitors represent a range of chemicals that, through their action on different signaling pathways and enzymatic activities, provide indirect means of influencing the vomeronasal 1 receptor 107. These inhibitors highlight the complex network of cellular signaling and molecular interactions that underpin receptor functionality, offering insights into potential methods of modulating receptor activity. This approach is crucial for understanding the broader implications of receptor regulation in physiological and behavioral responses.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Protein kinase C inhibitor, potentially impacting Vmn1r107 signaling through PKC-dependent pathways. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $88.00 $311.00 | 17 | |
Selective inhibitor of PKC, may indirectly influence Vmn1r107 activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
PKC inhibitor, could affect the receptor signaling indirectly. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Broad-spectrum kinase inhibitor, may indirectly modulate Vmn1r107-related pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, could affect Vmn1r107 signaling through the MAPK pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, possibly influencing Vmn1r107-related signaling via the PI3K/Akt pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Inhibits ROCK (Rho-associated protein kinase), potentially affecting Vmn1r107 signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor, could modulate Vmn1r107 function by affecting Src family kinase pathways. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, possibly influencing cAMP levels and thus Vmn1r107 signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, potentially influencing pathways associated with Vmn1r107. | ||||||